Sectors
The Axel Johnson-backes apparel fitting technology developer has been bought by a group of Japanese investors for $12.7m.
The drug developer, which is targeting chronic inflammation-related diseases, has raised series A cash two years after it spun out of Selvita.
Dementia Discovery Fund, backed by more than half a dozen corporates, reached its final close after AARP supplied $60m.
ING Ventures led a round for the blockchain trading technology developer that included fellow corporates BNP Paribas and Tech Mahindra.
Safety control equipment maker TTTech has received an undisclosed amount from B&C in return for a 9% equity stake.
The corporate-backed Space Camp Accelerator has welcomed its first six startups.
Abracar, the used car retailer spun off from Allianz X in early 2017, has received $13.4m in funding from the unit.
Axel Springer Media for Equity was among the investors as the financial coaching service closed its latest round at $11m.
Immuno-oncology drug developer iTeos Therapeutics has secured funding in a 6 Dimensions Capital-backed series B round.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
